Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Neurogenic inflammation and cardiac dysfunction due to hypomagnesemia.

Kramer JH, Spurney C, Iantorno M, Tziros C, Mak IT, Tejero-Taldo MI, Chmielinska JJ, Komarov AM, Weglicki WB.

Am J Med Sci. 2009 Jul;338(1):22-7. doi: 10.1097/MAJ.0b013e3181aaee4d. Review.

2.

The nerve-heart connection in the pro-oxidant response to Mg-deficiency.

Tejero-Taldo MI, Kramer JH, Mak IuT, Komarov AM, Weglicki WB.

Heart Fail Rev. 2006 Mar;11(1):35-44. Review.

PMID:
16819576
3.

Cytokines, neuropeptides, and reperfusion injury during magnesium deficiency.

Weglicki WB, Phillips TM, Mak IT, Cassidy MM, Dickens BF, Stafford R, Kramer JH.

Ann N Y Acad Sci. 1994 Jun 17;723:246-57.

PMID:
7518201
4.

Dietary magnesium intake influences circulating pro-inflammatory neuropeptide levels and loss of myocardial tolerance to postischemic stress.

Kramer JH, Mak IT, Phillips TM, Weglicki WB.

Exp Biol Med (Maywood). 2003 Jun;228(6):665-73.

PMID:
12773697
5.

Neutral endopeptidase inhibition enhances substance P mediated inflammation due to hypomagnesemia.

Weglicki WB, Chmielinska JJ, Tejero-Taldo I, Kramer JH, Spurney CF, Viswalingham K, Lu B, Mak IT.

Magnes Res. 2009 Sep;22(3):167S-173S.

6.

Cardiovascular and intestinal responses to oxidative and nitrosative stress during prolonged magnesium deficiency.

Weglicki WB, Chmielinska JJ, Kramer JH, Mak IT.

Am J Med Sci. 2011 Aug;342(2):125-8. doi: 10.1097/MAJ.0b013e318222e88c. Review.

PMID:
21747282
7.

Antioxidants and the cardiomyopathy of Mg-deficiency.

Weglicki WB, Bloom S, Cassidy MM, Freedman AM, Atrakchi AH, Dickens BF.

Am J Cardiovasc Pathol. 1992;4(3):210-5.

PMID:
1298297
8.

Magnesium-deficiency-enhanced post-ischemic myocardial injury is reduced by substance P receptor blockade.

Kramer JH, Phillips TM, Weglicki WB.

J Mol Cell Cardiol. 1997 Jan;29(1):97-110.

PMID:
9040025
9.

The role of magnesium deficiency in cardiovascular and intestinal inflammation.

Weglicki WB, Mak IuT, Chmielinska JJ, Tejero-Taldo MI, Komarov AM, Kramer JH.

Magnes Res. 2010 Dec;23(4):S199-206. doi: 10.1684/mrh.2010.0218. Epub 2010 Oct 25.

10.

Combination ART-Induced Oxidative/Nitrosative Stress, Neurogenic Inflammation and Cardiac Dysfunction in HIV-1 Transgenic (Tg) Rats: Protection by Mg.

Mak IT, Chmielinska JJ, Spurney CF, Weglicki WB, Kramer JH.

Int J Mol Sci. 2018 Aug 15;19(8). pii: E2409. doi: 10.3390/ijms19082409.

11.

N-methyl-D-aspartate receptor blockade inhibits cardiac inflammation in the Mg2+-deficient rat.

Tejero-Taldo MI, Chmielinska JJ, Gonzalez G, Mak IT, Weglicki WB.

J Pharmacol Exp Ther. 2004 Oct;311(1):8-13. Epub 2004 May 28.

PMID:
15169828
12.
13.

Substance P acts via the neurokinin receptor 1 to elicit bronchoconstriction, oxidative stress, and upregulated ICAM-1 expression after oil smoke exposure.

Li PC, Chen WC, Chang LC, Lin SC.

Am J Physiol Lung Cell Mol Physiol. 2008 May;294(5):L912-20. doi: 10.1152/ajplung.00443.2007. Epub 2008 Mar 7.

14.

Neurogenic peptides and the cardiomyopathy of magnesium-deficiency: effects of substance P-receptor inhibition.

Weglicki WB, Mak IT, Stafford RE, Dickens BF, Cassidy MM, Phillips TM.

Mol Cell Biochem. 1994 Jan 26;130(2):103-9.

PMID:
8028589
15.
16.

EGFR-TKI, erlotinib, causes hypomagnesemia, oxidative stress, and cardiac dysfunction: attenuation by NK-1 receptor blockade.

Mak IT, Kramer JH, Chmielinska JJ, Spurney CF, Weglicki WB.

J Cardiovasc Pharmacol. 2015 Jan;65(1):54-61. doi: 10.1097/FJC.0000000000000163.

17.

Blockade of cardiac inflammation in Mg2+ deficiency by substance P receptor inhibition.

Weglicki WB, Mak IT, Phillips TM.

Circ Res. 1994 May;74(5):1009-13.

PMID:
7512452
18.

Superoxide-mediated activation of cardiac fibroblasts by serum factors in hypomagnesemia.

Kumaran C, Shivakumar K.

Free Radic Biol Med. 2001 Oct 1;31(7):882-6.

PMID:
11585706
19.

Impaired oxidative metabolism and calcium mishandling underlie cardiac dysfunction in a rat model of post-acute isoproterenol-induced cardiomyopathy.

Willis BC, Salazar-Cantú A, Silva-Platas C, Fernández-Sada E, Villegas CA, Rios-Argaiz E, González-Serrano P, Sánchez LA, Guerrero-Beltrán CE, García N, Torre-Amione G, García-Rivas GJ, Altamirano J.

Am J Physiol Heart Circ Physiol. 2015 Mar 1;308(5):H467-77. doi: 10.1152/ajpheart.00734.2013. Epub 2014 Dec 19.

20.

Protease-activated receptor 2-mediated protection of myocardial ischemia-reperfusion injury: role of transient receptor potential vanilloid receptors.

Zhong B, Wang DH.

Am J Physiol Regul Integr Comp Physiol. 2009 Dec;297(6):R1681-90. doi: 10.1152/ajpregu.90746.2008. Epub 2009 Oct 7.

Supplemental Content

Support Center